Ceftriaxone and dexamethasone affecting yeast gut flora in experimental mice

被引:13
作者
Maraki, S [1 ]
Hajiioannou, I [1 ]
Anatoliotakis, N [1 ]
Plataki, M [1 ]
Chatzinikolaou, I [1 ]
Zoras, O [1 ]
Tselentis, Y [1 ]
Samonis, G [1 ]
机构
[1] Univ Crete, Div Med, Heraklion 71110, Crete, Greece
关键词
ceftriaxone; dexamethasone; gastrointestinal tract; Candida albicans;
D O I
10.1179/joc.1999.11.5.363
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Crl:CD1 (ICR) BR mice were fed regular food or food containing Candida albicans to induce gastrointestinal (GI) colonization by the yeast. Groups of colonized mice were subsequently treated with either ceftriaxone for 10 days or dexamethasone for 10 or 21 days. Another group of colonized mice was treated with the combination of ceftriaxone, given for 10 days, and dexamethasone given for 21 days. Other colonized mice received normal saline, and noncolonized mice received the same drugs or saline, serving as controls. Candida-colonized mice, treated either with ceftriaxone or with dexamethasone alone, had significantly increased levels of GI colonization by the yeast. Colonized mice treated with the combination of the antibiotic with dexamethasone had stool concentrations of Candida similar to those of mice treated with the antibiotic alone. Saline did not affect Candida stool concentration. Yeasts were not found in the stools of non-colonized mice treated with the study drugs or saline. There was no evidence of Candida dissemination to internal organs in any group.
引用
收藏
页码:363 / 366
页数:4
相关论文
共 24 条
[1]  
Anaisse E., 1992, CLIN INFECT DIS S1, V14, P43
[2]   MYK 1995 in Dresden [J].
Bernhardt, H .
MYCOSES, 1996, 39 :1-1
[3]   SYSTEMIC CANDIDIASIS IN MICE TREATED WITH PREDNISOLONE AND AMPHOTERICIN-B .1. MORBIDITY, MORTALITY AND INFLAMMATORY REACTION [J].
BLYTH, W ;
STEWART, GE .
MYCOPATHOLOGIA, 1978, 66 (1-2) :41-50
[4]   FUNGAL-INFECTIONS IN CANCER-PATIENTS - AN INTERNATIONAL AUTOPSY SURVEY [J].
BODEY, G ;
BUELTMANN, B ;
DUGUID, W ;
GIBBS, D ;
HANAK, H ;
HOTCHI, M ;
MALL, G ;
MARTINO, P ;
MEUNIER, F ;
MILLIKEN, S ;
NAOE, S ;
OKUDAIRA, M ;
SCEVOLA, D ;
VANTWOUT, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) :99-109
[5]   CORTICOSTEROIDS AND INFECTIOUS DISEASES [J].
DALE, DC ;
PETERSDO.RG .
MEDICAL CLINICS OF NORTH AMERICA, 1973, 57 (05) :1277-1287
[6]   FACTORS AFFECTING COLONIZATION AND DISSEMINATION OF CANDIDA-ALBICANS FROM THE GASTROINTESTINAL-TRACT OF MICE [J].
EKENNA, O ;
SHERERTZ, RJ .
INFECTION AND IMMUNITY, 1987, 55 (07) :1558-1563
[7]   GLUCOCORTICOSTEROID THERAPY - MECHANISMS OF ACTION AND CLINICAL CONSIDERATIONS [J].
FAUCI, AS ;
DALE, DC ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) :304-315
[8]  
FOLB PI, 1970, LANCET, V2, P1112
[9]  
FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
[10]   EXPERIMENTAL DISSEMINATED CANDIDIASIS .2. ADMINISTRATION OF GLUCOCORTICOSTEROIDS, SUSCEPTIBILITY TO INFECTION, AND IMMUNITY [J].
HURLEY, DL ;
BALOW, JE ;
FAUCI, AS .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (04) :393-398